Protein kinase C is involved in clozapine's facilitation of N-methyl-D-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex

Neuroscience

Volumn 118, Issue 2, 2003, Pages 501-512

  Jardemark, K E ^a   Ninan, I ^a,b   Liang, X ^a   Wang, R Y ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Antipsychotic drugs; Excitatory postsynaptic current; Glutamate; Schizophrenia; Signal transduction mechanism

Indexed keywords

CHELERYTHRINE; CLOZAPINE; N METHYLASPARTIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRIC POTENTIAL; ELECTRODE; EVOKED CORTICAL RESPONSE; FACILITATION; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; RECORDING; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; WILD TYPE;

EID: 0037426583     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00976-4     Document Type: Article

References (64)

1. Abeliovich A., Chen C., Goda Y., Silva A.J., Stevens C.F., Tonegawa S. Modified hippocampal long-term potentiation in PKC gamma-mutant mice. Cell. 75:1993;1253-1262.
2. Abeliovich A., Paylor R., Chen C., Kim J.J., Wehner J.M., Tonegawa S. PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning. Cell. 75:1993;1263-1271.
3. Abraham W.C., Tate W.P. Metaplasticity a new vista across the field of synaptic plasticity . Prog Neurobiol. 52:1997;303-323.
4. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E. Jr, Jones E.G. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci. 16:1996;19-30.
5. 2A receptor agonist DOB on NMDA-evoked responses in pyramidal neurons of the rat medial prefrontal cortex. Eur J Neurosci. 11:1999;2917-2934.
6. 2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex . Eur J Neurosci. 11:1999;3064-3072.
7. Arvanov V.L., Liang X., Schwartz J., Grossman S., Wang R.Y. Clozapine and haloperidol modulate NMDA- and non-NMDA receptor mediated neurotransmission in rat prefrontal cortical neurons in vitro. J Pharmacol Exp Ther. 283:1997;226-234.
8. Arvanov V.L., Wang R.Y. NMDA-evoked response in pyramidal neurons of the rat medial prefrontal cortex slices consists of NMDA and non-NMDA components. Brain Res. 768:1997;361-364.
9. 2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro. Neuropsychopharmacology. 18:1998;197-209.
10. Arvanov V.L., Wang R.Y. Clozapine, but not haloperidol, prevents the functional hyperactivity of NMDA receptors in rat cortical neurons induced by subchronic administration of phencyclidine. J Pharmacol Exp Ther. 289:1999;1000-1006.
11. + current in mice neocortical slices. J Neurophysiol. 80:1998;1547-1551.
12. Barria A., Muller D., Derkach V., Griffith L.C., Soderling T.R. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science. 276:1997;2042-2045.
13. Bayer K.U., De Koninck P., Leonard A.S., Hell J.W., Schulman H. Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature. 411:2001;801-805.
14. Beasley C.M. Jr, Tollefson G., Tran P., Satterlee W., Sanger T., Hamilton S. Olanzapine versus placebo and haloperidol acute phase results of the North American double-blind olanzapine trial . Neuropsychopharmacology. 14:1996;111-123.
15. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia implications for schizophrenia and Parkinson's disease . Trends Pharmacol Sci. 13:1990;272-276.
16. Cauli B., Audinat E., Lambolez B., Angulo M.C., Ropert N., Tsuzuki K., Hestrin S., Rossier J. Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci. 17:1997;3894-3906.
17. 2+-calmodulin and protein kinase Cs a hypothetical synthesis of their conflicting convergences on shared substrate domains . Trends Neurosci. 22:1999;12-16.
18. 2+ block of NMDA receptor channels as a mechanism of modulation. Nature. 356:1992;521-523.
19. 1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex. J Neurophysiol. 87:2002;2324-2336.
20. Connors B.W., Gutnick M.J. Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci. 13:1990;99-104.
21. Deutsch S.I., Mastropaolo J., Schwartz B.L., Rosse R.B., Morihisa J.M. A glutamatergic hypothesis of schizophrenia rationale for pharmacology with glycine . Clin Neuropharmacol. 12:1989;1-13.
22. Dracheva S., Marras S.A., Elhakem S.L., Kramer F.R., Davis K.L., Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry. 158:2001;1400-1410.
23. Dwivedi Y., Pandey G.N. Effects of treatment with haloperidol, chlorpromazine, and clozapine on protein kinase C and phosphoinositide-specific phospholipase activity and on mRNA and protein expression of PKC and PLC isozymes in rat brain. J Pharmacol Exp Ther. 291:1999;688-704.
24. Finkel A.S., Redman S.J. Optimal voltage clamping with single microelectrodes. Smith T.G., Lecar A., Redman S.J., Gage P.W. Voltage and patch clamping with microelectrodes. 1985;95-120 Williams and Wilkins, Baltimore.
25. + currents increases the excitability of rat neocortical pyramidal neurones. J Physiol. 528:2000;291-304.
26. Gerendasy D.D., Sutcliffe J.G. RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes. Mol Neurobiol. 15:1997;131-163.
27. Goda Y., Stevens C.F., Tonegawa S. Phorbol ester effects at hippocampal synapses act independently of the gamma isoform of PKC. Learn Mem. 3:1996;182-187.
28. 5 receptor activation modulates a persistent sodium current in rat prefrontal cortical neurons in vitro. J Neurophysiol. 84:2000;75-87.
29. Halliwell J.V., Adams P.R. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons. Brain Res. 250:1982;71-92.
30. Harrison P.J. The neuropathology of schizophrenia a critical review of the data and their interpretation . Brain. 122:1999;593-624.
31. 2 receptors and sigma receptors affect differentially the N-methyl-D-aspartate-induced increase in intracellular calcium concentration involvement of protein kinase . Synapse. 31:1999;20-28.
32. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 172:1990;993-999.
33. Holmes K., Keele B., Arvanov V., Shinnick-Gallagher P. Metabotropic glutamate receptor agonist-induced hyperpolarization in rat basolateral amygdala neurons receptor characterization, second messengers and ion channels . J Neurophysiol. 76:1996;3059-3069.
34. House C., Kemp B.E. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science. 238:1987;1726-1728.
35. Ishimaru M., Kurumaji A., Toru M. Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics evidence for glutamate hypothesis . Biol Psychiatry. 35:1994;84-95.
36. Jardemark K.E., Ai J., Ninan I., Wang R.Y. Biphasic modulation of NMDA-induced responses in pyramidal cells of the medial prefrontal cortex by Y-931, a potential atypical antipsychotic drug. Synapse. 41:2001;294-300.
37. Kawaguchi Y., Kubota Y. Physiological and morphological identification of somatostatin- or vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat frontal cortex. J Neurosci. 16:1996;2701-2715.
38. Kim J.S., Kornhuber H.H., Schmid-Burgk W., Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett. 20:1980;379-382.
39. Leveque J.C., Macias W., Rajadhyaksha A., Carlson R.R., Barczak A., Kang S., Li X.M., Coyle J.T., Huganir R.L., Heckers S., Konardi C. Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci. 20:2000;4011-4020.
40. Liang X., Jardemark K.E., Wang R.Y. Facilitation of the N-methyl-D-aspartate responses in pyramidal cells of the medial prefrontal cortex by clozapine role of protein kinase C . Soc Neurosci Abstr. 25:1999;2048.
41. Liao G.Y., Wagner D.A., Hsu M.H., Leonard J.P. Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. Mol Pharmacol. 59:2001;960-964.
42. Liu W.S., Heckman C.A. The sevenfold way of PKC regulation. Cell Signal. 10:1998;529-542.
43. MacDonald J.F., Kotecha S.A., Lu W.Y., Jackson M.F. Convergence of PKC-dependent kinase signal cascades on NMDA receptors. Curr Drug Targets. 2:2001;299-312.
44. Madison D.V., Lancaster B., Nicoll R.A. Voltage clamp analysis of cholinergic action in the hippocampus. J Neurosci. 7:1987;733-741.
45. Majumdar S., Kane L.H., Rossi M.W., Volpp B.D., Nauseef W.M., Korchak H.M. Protein kinase C isotypes and signal-transduction in human neutrophils selective substrate specificity of calcium-dependent beta-PKC and novel calcium-independent nPKC . Biochim Biophys Acta. 1176:1993;276-286.
46. Malinow R., Schulman H., Tsien R.W. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science. 245:1989;862-865.
47. McCormick D.A., Connors B.W., Lighthall J.W., Prince D.A. Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex. J Neurophysiol. 54:1985;782-806.
48. Naik M.U., Benedikz E., Hernandez I., Libien J., Hrabe E., Valsamis M., Dow-Edwards D., Osman M., Sacktor T.C. Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain. J Comp Neurol. 426:2000;243-258.
49. Ninan I., Jardemark K., Wang R.Y. Diffrential effects of atypical and typical antipsychotic drugs on NMDA receptor mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex. Soc Neurosci Abstr. 27:2001;664. 10.
50. Ninan I, Jardemark K, Liang X, Wang RY (2003) Calcium/calmodulin-dependent kinase II is involved in the facilitating effect of clozapine on NMDA- and electrically evoked responses in the medial prefrontal cortical pyramidal cells. Synapse 47:285-294.
51. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 52:1995;998-1007.
52. Rainnie D.G., Holmes K.H., Shinnick-Gallagher P. Activation of postsynaptic metabotropic glutamate receptors by trans-ACPD hyperpolarizes neurons of the basolateral amygdala. J Neurosci. 14:1994;7208-7220.
53. Schweitzer P., Madamba S., Champagnat J., Siggins G.R. Somatostatin inhibition of hippocampal CA1 pyramidal neurons mediation by arachidonic acid and its metabolites . J Neurosci. 13:1993;2033-2049.
54. Silva A.J., Paylor R., Wehner J.M., Tonegawa S. Impaired spatial learning in alpha-calcium-calmodulin kinases II mutant mice. Science. 257:1992;206-211.
55. Suen P.C., Wu K., Xu J.L., Lin S.Y., Levine E.S., Black I.B. NMDA receptor subunits in the postsynaptic density of rat brain expression and phosphorylation by endogenous protein kinases . Brain Res Mol Brain Res. 59:1998;215-228.
56. Tanaka E., North A.R. Action of 5-hydroxytryptamine on neurons of rat cingulate cortex. J Neurophysiol. 89:1993;1749-1757.
57. Tollefson G.D., Sanger T.M. Negative symptoms a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine . Am J Psychiatry. 154:1997;466-474.
58. Van der Zee E.A., Bolhuis J.J., Solomonia R.O., Horn G., Luiten P.G. Differential distribution of protein kinase C (PKC alpha beta and PKC gamma) isoenzyme immunoreactivity in the chick brain. Brain Res. 676:1995;41-52.
59. 2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice. Brain Res. 779:1998;309-313.
60. Wang R.Y., Liang X. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice. Neuropsychopharmacology. 19:1998;74-85.
61. Wang R.Y., Liang X., Jardemark K.E., Arvanov V. Facilitation of NMDA transmission by olanzapine. In: Olanzapine (Zyprexa). Tran P.V., Bymaster F., Tye N., Herrera J., Breier A., Tollefson G. a novel antipsychotic. 2000;114-131 Williams and Wilkins, Baltimore.
62. Wuarin J.P., Peacock W.J., Dubeck F.E. Single-electrode voltage clamp analysis of the N-methyl-D-aspartate component of synaptic responses in neocortical slices from children with intractable epilepsy. J Neurophysiol. 67:1992;84-93.
63. Yang C.R., Seamans J.K., Gorelova N. Electrophysiological and morphological properties of layers V-VI principal pyramidal cells in rat prefrontal cortex in vitro. J Neurosci. 16:1996;1904-1921.
64. Zheng X., Zhang L., Wang A.P., Bennett M.V., Zukin R.S. Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosporylation of N-methyl-D-aspartate receptor subunits. Proc Natl Acad Sci USA. 96:1999;15262-15267.